These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24023847)

  • 1. Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis.
    Myung DS; Park YL; Chung CY; Park HC; Kim JS; Cho SB; Lee WS; Lee KH; Lee JH; Joo YE
    PLoS One; 2013; 8(9):e73262. PubMed ID: 24023847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of Livin in gastric cancer.
    Chung CY; Park YL; Kim N; Park HC; Park HB; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
    Oncol Rep; 2013 Nov; 30(5):2520-8. PubMed ID: 24008725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo.
    Ou JM; Ye B; Qiu MK; Dai YX; Dong Q; Shen J; Dong P; Wang XF; Liu YB; Quan ZW; Fei ZW
    Int J Oncol; 2014 Jan; 44(1):276-84. PubMed ID: 24220265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence: correlations with pathology and outcome.
    Wang Y; Li Y; Zhou B; Zhang WY; Guan JT; Wang R; Yang L; Xia QJ; Zhou ZG; Sun XF
    Tumour Biol; 2014 Dec; 35(12):11791-8. PubMed ID: 25339450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livin enhances tumorigenesis by regulating the mitogen-activated protein kinase signaling pathway in human hypopharyngeal squamous cell carcinoma.
    Kim SA; Yoon TM; Lee DH; Lee JK; Park YL; Chung IJ; Joo YE; Lim SC
    Mol Med Rep; 2016 Jul; 14(1):515-20. PubMed ID: 27175933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Livin and the inhibition of tumor progression by Livin silencing in laryngohypopharyngeal cancer.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    In Vivo; 2014; 28(5):751-9. PubMed ID: 25189886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer.
    Kim HK; Kim SA; Jung EK; Lee KH; Lee JK; Kang HC; Joo YE; Lim SC; Yoon TM
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of livin, caspase-3, and ki-67 in the progression of human ampullary carcinoma.
    Xue D; Zuo K; Li X; Zhang T; Chen H; Cheng Y; Chen Y
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):525-31. PubMed ID: 23343959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress on Livin protein: an inhibitor of apoptosis.
    Yan B
    Mol Cell Biochem; 2011 Nov; 357(1-2):39-45. PubMed ID: 21617971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
    Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
    Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells.
    Yang D; Song X; Zhang J; Ye L; Wang S; Che X; Wang J; Zhang Z; Wang L
    Biosci Biotechnol Biochem; 2010; 74(5):1039-44. PubMed ID: 20460713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancer.
    Song YA; Park YL; Kim KY; Myung E; Chung CY; Cho SB; Lee WS; Jung YD; Kweon SS; Joo YE
    Pathol Int; 2012 Feb; 62(2):127-36. PubMed ID: 22243783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livin promotes the progression and metastasis of breast cancer through the regulation of epithelial‑mesenchymal transition via the p38/GSK3β pathway.
    Han Y; Zhang L; Wang W; Li J; Song M
    Oncol Rep; 2017 Dec; 38(6):3574-3582. PubMed ID: 29039608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.